Bifogade filer
Newbury Pharmaceuticals has entered into a partnership granting access to 6 registered products.
Kurs & Likviditet
Prenumeration
Du har en aktiv prenumeration.
Prenumerera på pressmeddelanden från Newbury Pharmaceuticals via email.
Du prenumererar på följande språk.
Välj vilka språk du vill prenumerera på.
Modular Finance AB kommer att hantera vissa av dina personuppgifter om du väljer att prenumerera. Mer information om vår personuppgiftshantering finns här.
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Läkemedel & Handel |
2023-10-06 13:00:00
Newbury has signed a contract with Amarox Limited to represent and distribute their products in Sweden and Denmark. As part of the agreement, Newbury and Amarox will seek to commercialize certain registered products during 2024 with the ambition to expand the portfolio with more products.
Newbury will act as local representative responsible for all commercial activities whereas Amarox will be responsible for registration, production and inventory.
“The partnership with Amarox demonstrates our commitment to being the local champion and alternative partner of choice for companies not being present in the Nordics. This is our second distribution partnership signed within a short period of time – and it further validates our business model.”